Walleye Trading’s Ra Pharmaceuticals, Inc. Common Stock RARX Stock Holding History

Walleye Trading’s Portfolio RARX Stock Details RARX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-45,000	Closed	-$2.16M	–	4868
2020 Q1	$2.16M	Buy	45,000 +7,446	+20%	+$346K	0.02%	781
2019 Q4	$1.76M	Buy	+37,554	New	+$1.66M	0.01%	1319

Other funds holding RARX

Daiwa Securities Group Tokyo, Japan $34.8B AUM 20.7% 1-Year Est. Return

Walleye Trading's RARX Position: Q2 2020 in Review

Walleye Trading sold out of Ra Pharmaceuticals, Inc. Common Stock (RARX) in Q2 2020, closing a stake of 45,000 shares — an estimated $2.16M sold.

Walleye Trading first reported a position in RARX in Q4 2019 and held it in 2 quarters. The position peaked at $2.16M in Q1 2020. 1 fund tracked by Wall St. Rank holds RARX as of Q2 2020.

Walleye Trading reported no remaining Ra Pharmaceuticals, Inc. Common Stock position as of Q2 2020 after selling out during the quarter.
Walleye Trading sold 45,000 Ra Pharmaceuticals, Inc. Common Stock shares in Q2 2020, an estimated $2.16M.
Walleye Trading first reported a position in Ra Pharmaceuticals, Inc. Common Stock in Q4 2019 and held it in 2 quarters.
Walleye Trading's Ra Pharmaceuticals, Inc. Common Stock position peaked at $2.16M in Q1 2020.
1 fund tracked by Wall St. Rank held Ra Pharmaceuticals, Inc. Common Stock as of Q2 2020.

Based on Walleye Trading's 13F filing for Q2 2020, filed 14 Aug 2020.